维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="KLUFT C"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Effect of oral contraceptive on haemostasis variables显示文摘	Kluft C Lasink M	1997	Thrombhae-most1997，78，：	1
2	4G/4G genotype of PAI - 1 gene is associated with reduced risk of stroke in elderly 显示文摘	Hoekstra T Geleijnse JM Kluft C	2003	Stroke2003，34，：	1
3	Determinants of C-reactive protein concentration in blood显示文摘	DEMAAT M P KLUFT C	2001	Ital Heart J2001，2，7：	1
4	The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast acting inhibitor of tissue - type plasmmogen activator after trauma显示文摘	KLUFT C VERHEIJEN J H JIE A F H	2005	Stand J Clirt Lab Invest2005，45，：	1
5	Plasminogen activator inhibitors显示文摘	Kluft C	1987	Blood1987，69，2：	1
6	The cardiovascilar risk factor plasminogen activator inhibitor type-1 is related to insulin resistance显示文摘	Potter Van Loon BJ Kluft C Radder JK	1993	Metabikusm1993，42，：	1
7	Effects of hormone treatment on hemostasis variables 显示文摘	Kluft C	2007	Climacteric2007，10，2：	1
8	The association between inflammation markers, coronary artery disease and smoking 显示文摘	De Maat MP Kluft C	2002	Vascul Pharmacol2002，39，3：	1
9	Pharmacokinetics of saruplase, a recombinant unglycosylated human single - chain urokinase - type plasminogen activator and its effects on flbrinolytic and haemostatic parameters in healthy male subjects显示文摘	De Boer A Kluft C Gerloff J	1993	Thromb Haemost1993，70，2：	1
10	Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1(PAI-1): conditions and therapeutic targets显示文摘	KLUFT C	1984	Fibrinolysis1984，8，1：	1
11	Determination of the habitual low blood level of C-re- active protein in individuals显示文摘	Kluft C de Maat MP	2001	Ital Heart J2001，2，3：	1
12	Metabolic profile of acontinuous versus a cyclic low-dose combined oral contraceptiveafter one year of use 显示文摘	Rad M Kluft C de Kam ML	2011	Eur J Contracept Reprod Health Care2011，16，2：	1
13	Proinflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment 显示文摘	Kluft C Leuven JA Helmerhorst FM	2002	Vasc Pharmacol2002，39，3：	1
14	A shift in balance between profibrinolytic and anti fibrinolytic factors causes enhanced fibrinolysis in cirrhosis显示文摘	Leebeek FW Kluft C Knot EA	1991	Gastroenterology1991，101，5：	1
15	Sensitive markers of inflammation make it possible to study the chronic process:the rise of interest in low levels of C -reactive protein显示文摘	Kluft C de Maat MPM	2002	Vasc Pharmacol2002，39，3：	1
16	Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderlymen and women显示文摘	Schuit AJ Scbouten EG Kluft C	1997	Thromb Haemost1997，78，23：	1
17	Genetic influences on fibrinogen, tissue plasminogen activator-antigen and yon Wille-brand factor in males and females 显示文摘	de Lange M de Geus EJ Kluft C	2006	Thromb Haemost2006，95，3：	1
18	The harmonization of quantitative test results of different D-dimer methods显示文摘	Merjer P Kluft C	2005	Semin Vasc Med2005，5，：	1
19	Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C - reactive protein 显示文摘	Kluft C Maat MPM	2002	Vasc Pharmacol2002，39，3：	1
20	Circadian variation of fibrinolytic activity in blood 显示文摘	Andreotti F Kluft C	1991	Chronobiol Int1991，8，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示